Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models

Malignant Mesothelioma (MM) is a rare and highly aggressive cancer that develops from mesothelial cells lining the pleura and other internal cavities, and is often associated with asbestos exposure. To date, no effective treatments have been made available for this pathology. Herein, we propose a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Peter R., Hoffmann, Fukun W., Premeaux, Thomas A., Fujita, Tsuyoshi, Soprana, Elisa, Panigada, Maddalena, Chew, Glen M., Richard, Guilhem, Hindocha, Pooja, Menor, Mark, Khadka, Vedbar S., Deng, Youping, Moise, Lenny, Ndhlovu, Lishomwa C., Siccardi, Antonio, Weinberg, Andrew D., De Groot, Anne S., Bertino, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688537/
https://www.ncbi.nlm.nih.gov/pubmed/31428586
http://dx.doi.org/10.3389/fonc.2019.00720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688537/
https://www.ncbi.nlm.nih.gov/pubmed/31428586
http://dx.doi.org/10.3389/fonc.2019.00720

Ejemplares similares